204 related articles for article (PubMed ID: 16564524)
1. Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture.
Cortizo AM; Sedlinsky C; McCarthy AD; Blanco A; Schurman L
Eur J Pharmacol; 2006 Apr; 536(1-2):38-46. PubMed ID: 16564524
[TBL] [Abstract][Full Text] [Related]
2. Osteogenic activity of vanadyl(IV)-ascorbate complex: evaluation of its mechanism of action.
Cortizo AM; Molinuevo MS; Barrio DA; Bruzzone L
Int J Biochem Cell Biol; 2006; 38(7):1171-80. PubMed ID: 16455285
[TBL] [Abstract][Full Text] [Related]
3. Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression.
Kanazawa I; Yamaguchi T; Yano S; Yamauchi M; Sugimoto T
Biochem Biophys Res Commun; 2008 Oct; 375(3):414-9. PubMed ID: 18721796
[TBL] [Abstract][Full Text] [Related]
4. A novel collagen-binding peptide promotes osteogenic differentiation via Ca2+/calmodulin-dependent protein kinase II/ERK/AP-1 signaling pathway in human bone marrow-derived mesenchymal stem cells.
Shin MK; Kim MK; Bae YS; Jo I; Lee SJ; Chung CP; Park YJ; Min do S
Cell Signal; 2008 Apr; 20(4):613-24. PubMed ID: 18248957
[TBL] [Abstract][Full Text] [Related]
5. Vanadyl(IV) complexes with saccharides. Bioactivity in osteoblast-like cells in culture.
Barrio DA; Cattáneo ER; Apezteguía MC; Etcheverry SB
Can J Physiol Pharmacol; 2006 Jul; 84(7):765-75. PubMed ID: 16998540
[TBL] [Abstract][Full Text] [Related]
6. Metformin regulates osteoblast and adipocyte differentiation of rat mesenchymal stem cells.
Gao Y; Xue J; Li X; Jia Y; Hu J
J Pharm Pharmacol; 2008 Dec; 60(12):1695-700. PubMed ID: 19000376
[TBL] [Abstract][Full Text] [Related]
7. Metformin reverses the deleterious effects of high glucose on osteoblast function.
Zhen D; Chen Y; Tang X
J Diabetes Complications; 2010; 24(5):334-44. PubMed ID: 19628413
[TBL] [Abstract][Full Text] [Related]
8. Metformin induces osteoblast differentiation via orphan nuclear receptor SHP-mediated transactivation of Runx2.
Jang WG; Kim EJ; Bae IH; Lee KN; Kim YD; Kim DK; Kim SH; Lee CH; Franceschi RT; Choi HS; Koh JT
Bone; 2011 Apr; 48(4):885-93. PubMed ID: 21147283
[TBL] [Abstract][Full Text] [Related]
9. Effect of metformin on bone marrow progenitor cell differentiation: in vivo and in vitro studies.
Molinuevo MS; Schurman L; McCarthy AD; Cortizo AM; Tolosa MJ; Gangoiti MV; Arnol V; Sedlinsky C
J Bone Miner Res; 2010 Feb; 25(2):211-21. PubMed ID: 19594306
[TBL] [Abstract][Full Text] [Related]
10. Metformin reverts deleterious effects of advanced glycation end-products (AGEs) on osteoblastic cells.
Schurman L; McCarthy AD; Sedlinsky C; Gangoiti MV; Arnol V; Bruzzone L; Cortizo AM
Exp Clin Endocrinol Diabetes; 2008 Jun; 116(6):333-40. PubMed ID: 18273753
[TBL] [Abstract][Full Text] [Related]
11. Response to mechanical strain in an immortalized pre-osteoblast cell is dependent on ERK1/2.
Fan X; Rahnert JA; Murphy TC; Nanes MS; Greenfield EM; Rubin J
J Cell Physiol; 2006 May; 207(2):454-60. PubMed ID: 16419041
[TBL] [Abstract][Full Text] [Related]
12. Metformin prevents anti-osteogenic in vivo and ex vivo effects of rosiglitazone in rats.
Sedlinsky C; Molinuevo MS; Cortizo AM; Tolosa MJ; Felice JI; Sbaraglini ML; Schurman L; McCarthy AD
Eur J Pharmacol; 2011 Oct; 668(3):477-85. PubMed ID: 21839072
[TBL] [Abstract][Full Text] [Related]
13. Nitroglycerin enhances proliferation and osteoblastic differentiation in human mesenchymal stem cells via nitric oxide pathway.
Huang L; Qiu N; Zhang C; Wei HY; Li YL; Zhou HH; Xiao ZS
Acta Pharmacol Sin; 2008 May; 29(5):580-6. PubMed ID: 18430366
[TBL] [Abstract][Full Text] [Related]
14. Preptin, another peptide product of the pancreatic beta-cell, is osteogenic in vitro and in vivo.
Cornish J; Callon KE; Bava U; Watson M; Xu X; Lin JM; Chan VA; Grey AB; Naot D; Buchanan CM; Cooper GJ; Reid IR
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E117-22. PubMed ID: 16912056
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide mediates 17beta-estradiol-stimulated human and rodent osteoblast proliferation and differentiation.
O'Shaughnessy MC; Polak JM; Afzal F; Hukkanen MV; Huang P; MacIntyre I; Buttery LD
Biochem Biophys Res Commun; 2000 Nov; 277(3):604-10. PubMed ID: 11062001
[TBL] [Abstract][Full Text] [Related]
16. Effects of continuous activation of vitamin D and Wnt response pathways on osteoblastic proliferation and differentiation.
Shi YC; Worton L; Esteban L; Baldock P; Fong C; Eisman JA; Gardiner EM
Bone; 2007 Jul; 41(1):87-96. PubMed ID: 17513186
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts.
Tang CH; Yang RS; Chien MY; Chen CC; Fu WM
Eur J Pharmacol; 2008 Jan; 579(1-3):40-9. PubMed ID: 17980360
[TBL] [Abstract][Full Text] [Related]
18. [Effects of OGP(10-14) and its derivative G38I on proliferation and differentiation of rat osteoblasts in vitro].
Liu HL; Ding XY; Qiu MC; Tian GJ; Wang DX
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(41):2905-9. PubMed ID: 16324363
[TBL] [Abstract][Full Text] [Related]
19. Mechanical stress-mediated Runx2 activation is dependent on Ras/ERK1/2 MAPK signaling in osteoblasts.
Kanno T; Takahashi T; Tsujisawa T; Ariyoshi W; Nishihara T
J Cell Biochem; 2007 Aug; 101(5):1266-77. PubMed ID: 17265428
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of estradiol on ethanol-induced bone loss involve inhibition of reactive oxygen species generation in osteoblasts and downstream activation of the extracellular signal-regulated kinase/signal transducer and activator of transcription 3/receptor activator of nuclear factor-kappaB ligand signaling cascade.
Chen JR; Shankar K; Nagarajan S; Badger TM; Ronis MJ
J Pharmacol Exp Ther; 2008 Jan; 324(1):50-9. PubMed ID: 17916759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
